---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-038426"
form_type: "8-K"
ticker: "DSS"
cik: "0000771999"
company_name: "DSS, INC."
filed_at: "2023-10-26T23:59:59+00:00"
generated_at: "2026-06-09T09:12:18.278373+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# DSS receives NYSE American low-price delisting notice; must cure by Apr 20, 2024

## Summary
- Received letter from NYSE American on Oct 20, 2023, citing low share price for substantial period.
- Continued listing conditioned on reverse stock split or sustained price improvement by Apr 20, 2024.
- Exchange may take accelerated delisting if shares trade at abnormally low levels.
- DSS intends to cure deficiency and return to compliance; stock will trade with .BC notation.

## SEC filing metadata
- accession: 0001493152-23-038426
- form_type: 8-K
- ticker: DSS
- cik: 0000771999
- company_name: DSS, INC.
- filed_at: 2023-10-26T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/771999/000149315223038426/0001493152-23-038426-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/771999/000149315223038426/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-038426
- JSON: https://secwatch.observer/filing/0001493152-23-038426.json
- Plain text: https://secwatch.observer/filing/0001493152-23-038426.txt

## Key facts
- Listing & Compliance Notices
  DSS, INC. received a nyse_american deficiency notice notice regarding other (rules 1003(f)(v)).
  - Exchange: nyse american
  - Notice: deficiency notice
  - Rules: 1003(f)(v)
  source text: October 20, 2023, DSS, Inc. (the “Company”) received a letter (the “Letter”) from the staff of NYSE American LLC (the “Exchange”) stating that the Company’s securities have been selling for a low price per share for a substantial period of time and, pursuant to Section 1003(f)(v) of the NYSE American Company Guide, the Company’s continued listing is predicated on it effecting a reverse stock split of its common stock or otherwise demonstrating sustained price improvement within a reasonable period of time, which the Exchange has determined to be no later than April 20, 2024. However, the Excha
  evidence_url: https://www.sec.gov/Archives/edgar/data/771999/000149315223038426/0001493152-23-038426-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.